Autologous blood injection more efficaious than corticosteroid for lateral epicondylitis .
This report has been verified
by one or more authors of the
original publication.
Injection of autologous blood versus corticosteroid for lateral epicondylitis: a randomised controlled study
J Orthop Surg (Hong Kong). 2014 Dec;22(3):333-780 patients with lateral epicondylitis were randomized to either autologous blood injection or corticosteroid (methylprednisolone) injection. The purpose of this study was to compare these injection therapies for pain, function, and grip strength over 6 months post-injection. Results within the first 2 weeks - 1 month of injection demonstrated favourable outcome with corticosteroid injection. However, results at 3 months shifted to favour autologous blood injection over corticosteroid injection.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
